As Ventana Board Rejects Takeover Bid, Roche Challenges Arizona Law, 'Poison Pill' Defense | GenomeWeb
This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
 
Roche has filed two lawsuits aimed at overturning an Arizona law and invalidating a “poison pill” defense that could delay or block its hostile bid to acquire Ventana Medical Systems for $3 billion.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.